Active · per the CBE, 28 September 2026

GENAPHAR

BE0416169095

Rechtspersoon Public limited company 1 establishment

GENAPHAR is a pharmacy in Brussel. Public Limited, started on 4 June 1976, 1 establishment.

Arteveldestraat 20, 1000 Brussel

Behind the company: BEGGA VANDEWALLE, ANNITA BOEL.

Active for

50 year, 3 months

Financials

Financial year 2025

GENAPHAR from Brussel, company number BE0416169095, closed financial year 2025 with a result of € 18,373 after tax. For that financial year GENAPHAR recorded a gross margin of € 18,365 and equity of € 97,645. Compared with financial year 2024, the result moved from € 10,305 to € 18,373. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 24, 2026.

What it is worth Growing

€ 97,645

▲ 23% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 18,373

▲ 78% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 78,052

▲ 18% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 35,645.

Debts at end 2025

Bank debt

€ 16,579

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 24,121

▼ 10% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 8,985

▲ 20% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € 49,204 € -23,376 € 17,035 € 18,365 ▲ 8%
Profit after taxes € 46,248 € -26,773 € 10,305 € 18,373 ▲ 78%
Equity € 95,739 € 68,967 € 79,272 € 97,645 ▲ 23%
Total debts € 20,625 € 20,587 € 50,841 € 49,685 ▼ 2%
Cash € 21,257 € 17,973 € 65,869 € 78,052 ▲ 18%
Retained profit € 33,739 € 6,967 € 17,272 € 35,645 ▲ 106%
Bank debt € 16,579 € 16,579 € 16,579 € 16,579
Balance sheet total € 116,364 € 89,554 € 130,113 € 147,330 ▲ 13%

Key figures of GENAPHAR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to GENAPHAR?

What happened at GENAPHAR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 18,373 (▲ 78% vs 2024). filed late Source: NBB ↗
  • GERY VANDEWALLE stepped down as director. NBB
  • New establishment in Brussel. KBO
  • Start of the company according to the CBE. KBO

In short

From € 46,248 profit in 2022 to € 18,373 profit in 2025.

Paid € 3,248 in corporate taxes since 2022.

Best year ever: 2022, with € 46,248 profit.

Original PDFs at the National Bank ↗

A new publication or filing at GENAPHAR? We notify you, reason included.

Follow GENAPHAR

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

  1. Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
  2. We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
  3. In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Yes, I want that
See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies
  • De Lijn 8 June 2026 New annual account 2025

    filed on 8 June 2026

    What was left

    € 20 k ▼ 91%

    Money in the bank

    € 178 k ▼ 98%

    Open the dossier →

  • NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
  • bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Real filings at the National Bank

Management

BEGGA VANDEWALLE ANNITA BOEL
GENAPHAR

Behind GENAPHAR are BEGGA VANDEWALLE and ANNITA BOEL.

See the full network in the app

Directors

According to the 2025 annual accounts

BEGGA VANDEWALLE

Managing director

ANNITA BOEL

Director

GERY VANDEWALLE

Director

· until 2026

Establishments

Establishment units

Physical locations of this company

Registered office

Arteveldestraat 20

1000 Brussel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0416.169.095
VAT number
BE 0416.169.095
Registered office
Arteveldestraat 20, 1000 Brussel
Names & denominations
GENAPHAR
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
4 June 1976
Peppol
Active · Active since 8 Dec 2025
Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

Frequently asked questions

What does GENAPHAR do?
GENAPHAR is a pharmacy in Brussel. Public Limited, started on 4 June 1976, 1 establishment.
What is the address of GENAPHAR?
The registered office of GENAPHAR is located at Arteveldestraat 20, 1000 Brussel.
Is GENAPHAR still active?
Yes. According to the CBE (28 September 2026) GENAPHAR is active, legal situation “Normale toestand”, started on 4 June 1976.
Is GENAPHAR registered on Peppol?
Yes, GENAPHAR is registered on the Peppol network with ID 0208:0416169095.
What is the enterprise number of GENAPHAR?
The enterprise number of GENAPHAR is BE0416169095.
When was GENAPHAR founded?
GENAPHAR was founded on 4 June 1976.